Mohammadhossein Gilzad Kohan


PhD in Pharmaceutical Sciences, University of Alberta, Edmonton, Canada
Doctor of Pharmacy (PharmD), University of Tehran, Iran


Dr. Gilzad Kohan’s interests include developing clinical and non-clinical PK/PD projects, which investigate pathophysiological changes in the action and disposition of the drugs. In addition, he is interested in chemical structure modification (including pro-drug synthesis) in order to improve pharmacokinetic (PK) properties of anti-cancer and anti-inflammatory drugs. Additionally, his research involves drug-disease interaction studies and nano-medicine design.

Scholarly Works

Journal Articles

Alfonso Ramirez, Kathleen A. Bielecki-Wilken, David Baker, Shabnam Sani, Hamed Gilzad- Kohan (2021 , April ). In vitro permeability, irritability, and release evaluation of commonly used topical diclofenac gel preparations (1, 5, and 10 ) . Int J Pharm Compounding

Gilzad-Kohan H, Jamali F (2021 ). Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2 . J Pharm Pharm Sci

4. Bakhteyar Hamid, Cassone Clayton, Hamed Gilzad-Kohan, Sani Shabnam N (2017 , September ). Kinetic Analysis of Drug Release from Compounded Slow-Release Capsules of Liothyronine Sodium (T3) . Int J Pharm Compounding

Gilzad-Kohan H, Sani S, Boroujerdi M. (2017 , June ). Calcitriol Reverses Induced Expression of Efflux Proteins and Potentiates Cytotoxic Activity of Gemcitabine in Capan-2 Pancreatic Cancer Cells . J Pharm Pharm Sci

Vandhana Muralidharan-Chari, Hamed Gilzad-Kohan, Alex Asimakopoulos, Thangirala Sudha, Stewart Sell, Kannan Kurunthachalam, Mehdi Boroujerdi, Shaker A Mousa (2015 ). Removal of Therapeutic Drugs by Microvesicles Contributes to Drug Resistance in Cancer Cells .

Gilzad-Kohan, M.H Boroujerdi, M (2015 ). Time Course and dose dependency of Influx and Efflux Protein Expression after Treatment with Gemcitabine in Pancreatic Cancer Cells . Xenobiotica , 1-11.

Gilzad-Kohan, M.H. Kaur, K. Jamali, F (2015 ). A Novel Peptide Pro-drug of Glucosamine with Enhanced Gut Permeability . PLoS One

Gilzad-Kohan, M. H. K. Kaur and Jamali, F. (2013 ). The Antiinflammatory Action and Pharmacokinetics of a Novel Di-Peptide Aminosugar . J Pharm Pharm Sci ,16 , 279-288.

Agahzadeh-Habashi, A. Gilzad-Kohan, M. Jamali, F. (2013 ). Glucosamine Dose-Effect Correlation in Adjuvant Arthritis Rat . Journal of Osteoarthritis Cartilage

Gilzad-Kohan, M. H. Jamali, F. (2012 ). Glucosamine and adjuvant arthritis: a pharmacokinetic and pharmacodynamic study . Eur. J. Pharm. Sci. ,47 , 387-393.

Ibrahim, A. Gilzad-Kohan, M. H. Aghazadeh-Habashi, A. Jamali, F. (2012 ). Absorption and bioavailability of glucosamine in the rat . J. Pharm. Sci. ,101 , 2574-2583.

M. H. D. Kamal Al-Hallak, Muhammad Khan Sarfraz, Shirzad Azarmi, M. H. Gilzad Kohan, Wilson H. Roa, and Raimar Löbenberg (2011 , March ). Microcalorimetric Method to Assess Phagocytosis: Macrophage-Nanoparticle Interactions . AAPS J. ,13 , 20-29.

Courses Taught

PHAR 514 Pharmaceutics I

PHAR 515 Pharmaceutics I Lab

PHAR 610 Principles of Pharmacokinetics

PHAR 525 Pharmaceutics lab

PHAR 656 Drug Discovery & Development

PHAR 690 Cosmeceuticals